(Press-News.org) Contact information: Linda Stepanich
lstepanich@yahoo.com
847-682-3251
American College of Chest Physicians
Beta-blockers may increase adverse cardiac events, patients at risk during noncardiac surgical procedure
(Chicago, Illinois) October 28, 2013 - A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree. Beta-blockers are drugs commonly prescribed to treat high blood pressure and congestive heart failure. The study was presented during CHEST 2013, the annual meeting of the American College of Chest Physicians (ACCP), held October 26-31 in Chicago.
Researchers at State University of New York (SUNY)-Upstate Medical University Hospital analyzed 755 patients who had undergone noncardiac surgery in a single university-based center, with patients randomly chosen and subclassified according to gender, ethnicity, risk of surgery, and whether beta-blockers were used before, during, or after a noncardiac surgical procedure. Six different outcomes were investigated in the study: all-cause mortality, acute coronary syndrome (ACS), irregular heartbeat, cardiac event-related death, worsening of symptoms in a patient who has existing heart disease, and slower-than-normal heart rate. Three variables were used to predict these outcomes: beta-blocker administration, revised cardiac index score (RCRI)—a prediction of assessing risk of cardiac complications, and risk of surgery. Beta-blocker use was found to increase the odds of having an acute coronary event.
"The results from this study become especially important in view of the fact that beta-blockers are currently recommended by the American College of Cardiology/American Heart Association (ACC/AHA) 2011 guidelines regarding cardiac risk and management before, during and after surgery," said David D. Gutterman, MD, FCCP and past president of the ACCP.
###
CHEST 2013 is the 79th annual meeting of the American College of Chest Physicians, held October 26-31 in Chicago, Illinois. The ACCP is the global leader in clinical chest medicine, representing 18,700 members who provide patient care in the areas of pulmonary, critical care, and sleep medicine in the United States and throughout the world. The mission of the ACCP is to promote the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. For information about the ACCP, visit the ACCP website at http://www.chestnet.org, or follow the ACCP on Facebook and Twitter and the meeting hashtag, #CHEST2013.
Beta-blockers may increase adverse cardiac events, patients at risk during noncardiac surgical procedure
2013-10-28
ELSE PRESS RELEASES FROM THIS DATE:
Exhaled breath biomarker may detect lung cancer, study presented at Chest 2013
2013-10-28
Exhaled breath biomarker may detect lung cancer, study presented at Chest 2013
"We believe that cancer cells release a unique chemical signature related to the tumor-growing process," said Peter J. Mazzone, MD, FCCP, director of the lung cancer ...
Electronic intensive care units (eICUs) effective in providing remote care, study presented at CHEST
2013-10-28
Electronic intensive care units (eICUs) effective in providing remote care, study presented at CHEST
An eICU uses telecommunications technology to diagnose and treat patients in the ICU remotely. Using two-way cameras, video monitors, microphones, ...
Burden of futile care in ICU studied: Patients waiting for care affected negatively, study presented
2013-10-28
Burden of futile care in ICU studied: Patients waiting for care affected negatively, study presented
On a daily basis for a period of 3 months, researchers surveyed critical care physicians in five ICUs in one health-care system to identify patients ...
Smoking long or ultralong cigarettes increases risk of lung cancer, study released at CHEST 2013
2013-10-28
Smoking long or ultralong cigarettes increases risk of lung cancer, study released at CHEST 2013
"We found that of smokers of long or ultralong cigarettes have higher concentrations of tobacco specific carcinogens in their urine than smokers of ...
X-rays overused in ICU: Ultrasound safer, just as effective
2013-10-28
X-rays overused in ICU: Ultrasound safer, just as effective
"We found that the use of ultrasound to diagnose patients greatly reduced radiation exposure for patients without negatively affecting their health," said Margarita Oks, MD, Long Island ...
Yoga practice beneficial to patients with COPD
2013-10-28
Yoga practice beneficial to patients with COPD
An estimated 24 million Americans may have COPD, which includes chronic bronchitis, emphysema, or both. Patients with COPD have trouble pushing used air out of their lungs, making it difficult to take ...
New mechanism underlying Danhong injection for cerebral ischemia-reperfusion injury
2013-10-28
New mechanism underlying Danhong injection for cerebral ischemia-reperfusion injury
Transforming growth factor-β1 is a universal multifunctional polypeptide cytokine, which has been shown to have a protective effect against nerve cell damage. Golgi morphology ...
Is size of the corpus callosum a screening index for neurodevelopment abnormalities?
2013-10-28
Is size of the corpus callosum a screening index for neurodevelopment abnormalities?
The corpus callosum is the largest white matter fiber bundle in the human brain, the major interhemispheric commissure that connects the majority of the neocortical areas, and ...
A nanofibrous conduit suitable for repair of long-segment sciatic nerve defects
2013-10-28
A nanofibrous conduit suitable for repair of long-segment sciatic nerve defects
Autografts or allografts are commonly used in neurosurgery. Unfortunately, autografts have limitations such as body injury, repeated surgeries and disproportion of grafted nerve tissue ...
Data shows VisionGate's 3D imaging platform accurately detects lung cancer in sputum
2013-10-28
Data shows VisionGate's 3D imaging platform accurately detects lung cancer in sputum
Data at IASLC demonstrate feasibility of using sputum and the Cell-CT platform to non-invasively detect the presence or absence of lung cancer; initially for adjunctive use ...